- Home
- GSBC vs GKOS Comparison
GSBC vs GKOS Comparison
Compare GSBC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- GKOS
- Stock Information
- Founded
- GSBC 1923
- GKOS 1998
- Country
- GSBC United States
- GKOS United States
- Employees
- GSBC N/A
- GKOS N/A
- Industry
- GSBC Major Banks
- GKOS Medical/Dental Instruments
- Sector
- GSBC Finance
- GKOS Health Care
- Exchange
- GSBC Nasdaq
- GKOS Nasdaq
- Market Cap
- GSBC 665.7M
- GKOS 5.8B
- IPO Year
- GSBC N/A
- GKOS 2015
- Fundamental
- Price
- GSBC $62.51
- GKOS $103.50
- Analyst Decision
- GSBC Hold
- GKOS Strong Buy
- Analyst Count
- GSBC 2
- GKOS 13
- Target Price
- GSBC $59.50
- GKOS $135.15
- AVG Volume (30 Days)
- GSBC 84.2K
- GKOS 903.0K
- Earning Date
- GSBC 07-16-2025
- GKOS 07-30-2025
- Dividend Yield
- GSBC 2.56%
- GKOS N/A
- EPS Growth
- GSBC 10.52
- GKOS N/A
- EPS
- GSBC 5.60
- GKOS N/A
- Revenue
- GSBC $219,572,000.00
- GKOS $404,523,000.00
- Revenue This Year
- GSBC N/A
- GKOS $27.88
- Revenue Next Year
- GSBC $1.04
- GKOS $27.60
- P/E Ratio
- GSBC $11.16
- GKOS N/A
- Revenue Growth
- GSBC N/A
- GKOS 23.92
- 52 Week Low
- GSBC $47.58
- GKOS $77.10
- 52 Week High
- GSBC $68.02
- GKOS $163.71
- Technical
- Relative Strength Index (RSI)
- GSBC 72.96
- GKOS 61.38
- Support Level
- GSBC $58.58
- GKOS $100.92
- Resistance Level
- GSBC $60.00
- GKOS $106.52
- Average True Range (ATR)
- GSBC 1.35
- GKOS 3.30
- MACD
- GSBC 0.59
- GKOS 0.37
- Stochastic Oscillator
- GSBC 95.08
- GKOS 71.27
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.